메뉴 건너뛰기




Volumn 9, Issue 3, 2004, Pages 221-236

The genetic epidemiology of breast cancer genes

Author keywords

ATM; BRCA1; BRCA2; Breast cancer; CHEK2; PTEN; TP53

Indexed keywords

APC PROTEIN; ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CHECKPOINT KINASE 2; ESTROGEN RECEPTOR; ORAL CONTRACEPTIVE AGENT; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGESTERONE RECEPTOR; PROTEIN P53; TAMOXIFEN;

EID: 9144251028     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOMG.0000048770.90334.3b     Document Type: Review
Times cited : (208)

References (129)
  • 1
    • 0035960431 scopus 로고    scopus 로고
    • Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease
    • Collaborative Group on Hormonal Factors in Breast Cancer
    • Collaborative Group on Hormonal Factors in Breast Cancer (2001). Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358:1389-1399.
    • (2001) Lancet , vol.358 , pp. 1389-1399
  • 3
    • 0033667308 scopus 로고    scopus 로고
    • High constant incidence in twins and other relatives of women with breast cancer
    • J. Peto, and T. M. Mack (2000). High constant incidence in twins and other relatives of women with breast cancer. Nat. Genet. 26: 11-414.
    • (2000) Nat. Genet. , vol.26 , pp. 411-414
    • Peto, J.1    Mack, T.M.2
  • 10
    • 0030044822 scopus 로고    scopus 로고
    • Cancer mortality in relatives of women with ovarian cancer: The OPCS Study
    • Office of Population Censuses and Surveys
    • D. F. Easton, F. E. Matthews, D. Ford, A. J. Swerdlow, and J. Peto (1996). Cancer mortality in relatives of women with ovarian cancer: The OPCS Study. Office of Population Censuses and Surveys. Int. J. Cancer. 65:284-294.
    • (1996) Int. J. Cancer , vol.65 , pp. 284-294
    • Easton, D.F.1    Matthews, F.E.2    Ford, D.3    Swerdlow, A.J.4    Peto, J.5
  • 11
    • 0030060104 scopus 로고    scopus 로고
    • Cancer mortality in relatives of women with breast cancer: The OPCS Study
    • Office of Population Censuses and Surveys
    • J. Peto, D. F. Easton, F. E. Matthews, D. Ford, and A. J. Swerdlow (1996). Cancer mortality in relatives of women with breast cancer: The OPCS Study. Office of Population Censuses and Surveys. Int. J. Cancer. 65:275-283.
    • (1996) Int. J. Cancer , vol.65 , pp. 275-283
    • Peto, J.1    Easton, D.F.2    Matthews, F.E.3    Ford, D.4    Swerdlow, A.J.5
  • 13
    • 0026935108 scopus 로고
    • Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome
    • S. A. Smith, D. F. Easton, D. G. Evans, and B. A. Ponder (1992). Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat. Genet. 2:128-131.
    • (1992) Nat. Genet. , vol.2 , pp. 128-131
    • Smith, S.A.1    Easton, D.F.2    Evans, D.G.3    Ponder, B.A.4
  • 14
    • 0035057806 scopus 로고    scopus 로고
    • BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
    • P. L. Welcsh, and M. C. King (2001). BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum. Mol. Genet. 10:705-713.
    • (2001) Hum. Mol. Genet. , vol.10 , pp. 705-713
    • Welcsh, P.L.1    King, M.C.2
  • 15
    • 0038364017 scopus 로고    scopus 로고
    • Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families
    • M. Montagna, P. M. Dalla, C. Menin, S. Agata, A. De Nicolo, L. Chieco-Bianchi, and E. D'Andrea (2003). Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum. Mol. Genet. 12: 055-1061.
    • (2003) Hum. Mol. Genet. , vol.12 , pp. 1055-1061
    • Montagna, M.1    Dalla, P.M.2    Menin, C.3    Agata, S.4    De Nicolo, A.5    Chieco-Bianchi, L.6    D'Andrea, E.7
  • 17
    • 0029939505 scopus 로고    scopus 로고
    • Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations
    • F. Durocher, D. Shattuck-Eidens, M. McClure, F. Labrie, M. H. Skolnick, D. E. Goldgar, and J. Simard (1996). Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. Hum. Mol. Genet. 5: 35-842.
    • (1996) Hum. Mol. Genet. , vol.5 , pp. 835-842
    • Durocher, F.1    Shattuck-Eidens, D.2    McClure, M.3    Labrie, F.4    Skolnick, M.H.5    Goldgar, D.E.6    Simard, J.7
  • 25
    • 0029680501 scopus 로고    scopus 로고
    • A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals
    • D. B. Berman, J. Costalas, D. C. Schultz, G. Grana, M. Daly, and A. K. Godwin (1996). A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. Cancer Res. 56:3409-3414.
    • (1996) Cancer Res. , vol.56 , pp. 3409-3414
    • Berman, D.B.1    Costalas, J.2    Schultz, D.C.3    Grana, G.4    Daly, M.5    Godwin, A.K.6
  • 33
    • 0031035359 scopus 로고    scopus 로고
    • The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women
    • D. Abeliovich, L. Kaduri, I. Lerer, N. Weinberg, G. Amir, M. Sagi, J. Zlotogora, N. Heching, and T. Peretz (1997). The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am. J. Hum. Genet. 60:505-514.
    • (1997) Am. J. Hum. Genet. , vol.60 , pp. 505-514
    • Abeliovich, D.1    Kaduri, L.2    Lerer, I.3    Weinberg, N.4    Amir, G.5    Sagi, M.6    Zlotogora, J.7    Heching, N.8    Peretz, T.9
  • 40
    • 0030051903 scopus 로고    scopus 로고
    • Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities
    • L. C. Gowen, B. L. Johnson, A. M. Latour, K. K. Sulik, and B. H. Koller (1996). Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet. 12:191-194.
    • (1996) Nat. Genet. , vol.12 , pp. 191-194
    • Gowen, L.C.1    Johnson, B.L.2    Latour, A.M.3    Sulik, K.K.4    Koller, B.H.5
  • 42
    • 0035065040 scopus 로고    scopus 로고
    • Apparent human BRCA1 knockout caused by mispriming during polymerase chain reaction: Implications for genetic testing
    • B. Kuschel, S. A. Gayther, D. F. Easton, B. A. Ponder, and P. D. Pharoah (2001). Apparent human BRCA1 knockout caused by mispriming during polymerase chain reaction: Implications for genetic testing. Genes Chromosomes Cancer 31:96-98.
    • (2001) Genes Chromosomes Cancer , vol.31 , pp. 96-98
    • Kuschel, B.1    Gayther, S.A.2    Easton, D.F.3    Ponder, B.A.4    Pharoah, P.D.5
  • 46
    • 0028843102 scopus 로고
    • Breast and ovarian cancer incidence in BRCA1-mutation carriers
    • and Breast Cancer Linkage Consortium
    • D. F. Easton, D. Ford, D. T. Bishop, and Breast Cancer Linkage Consortium (1995). Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am. J. Hum. Genet. 56:265-271.
    • (1995) Am. J. Hum. Genet. , vol.56 , pp. 265-271
    • Easton, D.F.1    Ford, D.2    Bishop, D.T.3
  • 47
    • 0142178215 scopus 로고    scopus 로고
    • Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
    • M. C. King, J. H. Marks, and J. B. Mandell (2003). Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643-646.
    • (2003) Science , vol.302 , pp. 643-646
    • King, M.C.1    Marks, J.H.2    Mandell, J.B.3
  • 49
    • 0036123926 scopus 로고    scopus 로고
    • Variation in BRCA1 cancer risks by mutation position
    • Breast Cancer Linkage Consortium
    • D. Thompson, and D. Easton (2002). Breast Cancer Linkage Consortium. Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol. Biomarkers Prev. 11:329-336.
    • (2002) Cancer Epidemiol. Biomarkers Prev. , vol.11 , pp. 329-336
    • Thompson, D.1    Easton, D.2
  • 50
    • 0035125062 scopus 로고    scopus 로고
    • Variation in cancer risks, by mutation position, in BRCA2 mutation carriers
    • D. Thompson, and D. Easton (2001). Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am. J. Hum. Genet. 68: 10-419.
    • (2001) Am. J. Hum. Genet. , vol.68 , pp. 410-419
    • Thompson, D.1    Easton, D.2
  • 51
    • 0031012305 scopus 로고    scopus 로고
    • Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene
    • S. A. Gayther, J. Mangion, P. Russell, S. Seal, R. Barfoot, B. A. Ponder, M. R. Stratton, and D. Easton (1997). Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat. Genet. 15:103-105.
    • (1997) Nat. Genet. , vol.15 , pp. 103-105
    • Gayther, S.A.1    Mangion, J.2    Russell, P.3    Seal, S.4    Barfoot, R.5    Ponder, B.A.6    Stratton, M.R.7    Easton, D.8
  • 53
    • 0033740880 scopus 로고    scopus 로고
    • Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases
    • Anglian Breast Cancer Study Group
    • Anglian Breast Cancer Study Group (2000). Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br. J. Cancer 83:1301-1308.
    • (2000) Br. J. Cancer , vol.83 , pp. 1301-1308
  • 56
    • 0032565074 scopus 로고    scopus 로고
    • BRCA1 mutations and breast cancer in the general population: Analyses in women before age 35 years and in women before age 45 years with first-degree family history
    • K. E. Malone, J. R. Dating, J. D. Thompson, C. A. O'Brien, L. V. Francisco, and E. A. Ostrander (1998). BRCA1 mutations and breast cancer in the general population: Analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA 279:922-929.
    • (1998) JAMA , vol.279 , pp. 922-929
    • Malone, K.E.1    Dating, J.R.2    Thompson, J.D.3    O'Brien, C.A.4    Francisco, L.V.5    Ostrander, E.A.6
  • 57
    • 0032565070 scopus 로고    scopus 로고
    • Frequency of breast cancer attributable to BRCA1 in a population-based series of American women
    • B. Newman, H. Mu, L. M. Butler, R. C. Millikan, P. G. Moorman, and M. C. King (1998). Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 279:915-921.
    • (1998) JAMA , vol.279 , pp. 915-921
    • Newman, B.1    Mu, H.2    Butler, L.M.3    Millikan, R.C.4    Moorman, P.G.5    King, M.C.6
  • 58
    • 0032826284 scopus 로고    scopus 로고
    • Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2
    • and Australian Breast Cancer Family Study
    • J. L. Hopper, M. C. Southey, G. S. Dite, D. J. Jolley, G. G. Giles, M. R. McCredie, D. F. Easton, D. J. Venter, and Australian Breast Cancer Family Study (1999). Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Cancer Epidemiol. Biomarkers Prev. 8:741-747.
    • (1999) Cancer Epidemiol. Biomarkers Prev. , vol.8 , pp. 741-747
    • Hopper, J.L.1    Southey, M.C.2    Dite, G.S.3    Jolley, D.J.4    Giles, G.G.5    McCredie, M.R.6    Easton, D.F.7    Venter, D.J.8
  • 59
    • 0035880897 scopus 로고    scopus 로고
    • Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer
    • N. Loman, O. Johannsson, U. Kristoffersson, H. Olsson, and A. Borg (2001). Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J. Natl. Cancer Inst. 93:1215-1223.
    • (2001) J. Natl. Cancer Inst. , vol.93 , pp. 1215-1223
    • Loman, N.1    Johannsson, O.2    Kristoffersson, U.3    Olsson, H.4    Borg, A.5
  • 60
    • 0028826709 scopus 로고
    • Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence
    • D. Ford, D. F. Easton, and J. Peto (1995). Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am. J. Hum. Genet. 57:1457-1462.
    • (1995) Am. J. Hum. Genet. , vol.57 , pp. 1457-1462
    • Ford, D.1    Easton, D.F.2    Peto, J.3
  • 65
    • 0032053728 scopus 로고    scopus 로고
    • BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease
    • K. Haraldsson, N. Loman, Q. X. Zhang, O. Johannsson, H. Olsson, and A. Borg (1998). BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res. 58:1367-1371.
    • (1998) Cancer Res. , vol.58 , pp. 1367-1371
    • Haraldsson, K.1    Loman, N.2    Zhang, Q.X.3    Johannsson, O.4    Olsson, H.5    Borg, A.6
  • 67
    • 0030825927 scopus 로고    scopus 로고
    • Germline BRCA2 mutations in men with breast cancer
    • E. Mavraki, I. C. Gray, D. T. Bishop, and N. K. Spurr (1997). Germline BRCA2 mutations in men with breast cancer. Br. J. Cancer 76: 428-1431.
    • (1997) Br. J. Cancer , vol.76 , pp. 1428-1431
    • Mavraki, E.1    Gray, I.C.2    Bishop, D.T.3    Spurr, N.K.4
  • 69
    • 0342940785 scopus 로고    scopus 로고
    • Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases
    • Breast Cancer Linkage Consortium
    • Breast Cancer Linkage Consortium (1997). Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349:1505-1510.
    • (1997) Lancet , vol.349 , pp. 1505-1510
  • 72
    • 0034091778 scopus 로고    scopus 로고
    • Survival and tumor characteristics of German hereditary breast cancer patients
    • U. Hamann, and H. P. Sinn (2000). Survival and tumor characteristics of German hereditary breast cancer patients. Breast Cancer Res. Treat. 59:185-192.
    • (2000) Breast Cancer Res. Treat. , vol.59 , pp. 185-192
    • Hamann, U.1    Sinn, H.P.2
  • 74
    • 0033820798 scopus 로고    scopus 로고
    • BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer
    • D. Turchetti, L. Cortesi, M. Federico, C. Bertoni, L. Mangone, S. Ferrari, and V. Silingardi (2000). BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer. Eur. J. Cancer 36:2083-2089.
    • (2000) Eur. J. Cancer , vol.36 , pp. 2083-2089
    • Turchetti, D.1    Cortesi, L.2    Federico, M.3    Bertoni, C.4    Mangone, L.5    Ferrari, S.6    Silingardi, V.7
  • 77
    • 0036569877 scopus 로고    scopus 로고
    • The pathology of familial breast cancer: Predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2
    • S. R. Lakhani, M. J. van de Vijver, J. Jacquemier, T. J. Anderson, P. P. Osin, L. McGuffog, and D. F. Easton (2002). The pathology of familial breast cancer: Predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J. Clin. Oncol. 20:2310-2318.
    • (2002) J. Clin. Oncol. , vol.20 , pp. 2310-2318
    • Lakhani, S.R.1    van de Vijver, M.J.2    Jacquemier, J.3    Anderson, T.J.4    Osin, P.P.5    McGuffog, L.6    Easton, D.F.7
  • 83
    • 0037130887 scopus 로고    scopus 로고
    • Cancer incidence in BRCA1 mutation carriers
    • D. Thompson, and D. F. Easton (2002). Cancer incidence in BRCA1 mutation carriers. J. Natl. Cancer Inst. 94:1358-1365.
    • (2002) J. Natl. Cancer Inst. , vol.94 , pp. 1358-1365
    • Thompson, D.1    Easton, D.F.2
  • 84
    • 0033523268 scopus 로고    scopus 로고
    • Cancer risks in BRCA2 mutation carriers
    • Breast Cancer Linkage Consortium
    • Breast Cancer Linkage Consortium (1999). Cancer risks in BRCA2 mutation carriers. J. Natl. Cancer Inst. 91:1310-1316.
    • (1999) J. Natl. Cancer Inst. , vol.91 , pp. 1310-1316
  • 89
    • 0037017867 scopus 로고    scopus 로고
    • Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women
    • E3N-EPIC Group
    • F. Clavel-Chapelon, E3N-EPIC Group (2002). Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br. J. Cancer 86:723-727.
    • (2002) Br. J. Cancer , vol.86 , pp. 723-727
    • Clavel-Chapelon, F.1
  • 90
    • 0027092659 scopus 로고
    • Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II: Invasive epithelial ovarian cancers in white women
    • Collaborative Ovarian Cancer Group
    • A. S. Whittemore, R. Harris, and J. Itnyre (1992). Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II: Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am. J. Epidemiol. 136:1184-1203.
    • (1992) Am. J. Epidemiol. , vol.136 , pp. 1184-1203
    • Whittemore, A.S.1    Harris, R.2    Itnyre, J.3
  • 105
    • 18544389716 scopus 로고    scopus 로고
    • CHK2 1100delC is a low penetrance familial breast cancer susceptibility allele that does not elevate breast cancer in BRCA1/2 mutation carriers
    • H. Meijers-Heijboer. (2002). CHK2 1100delC is a low penetrance familial breast cancer susceptibility allele that does not elevate breast cancer in BRCA1/2 mutation carriers. Nat. Genet. 31:55-59.
    • (2002) Nat. Genet. , vol.31 , pp. 55-59
    • Meijers-Heijboer, H.1
  • 107
    • 3042582651 scopus 로고    scopus 로고
    • CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9065 controls from 10 studies
    • CHEK2 Breast Cancer Case-Control Consortium
    • CHEK2 Breast Cancer Case-Control Consortium (2004). CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9065 controls from 10 studies. Am. J. Hum. Genet. 74:1175-1182.
    • (2004) Am. J. Hum. Genet. , vol.74 , pp. 1175-1182
  • 110
    • 0028575693 scopus 로고
    • Cancer risks in A-T heterozygotes
    • D. F. Easton (1994). Cancer risks in A-T heterozygotes. Int. J. Radiat Biol. 66:S177-S182.
    • (1994) Int. J. Radiat. Biol. , vol.66
    • Easton, D.F.1
  • 117
    • 0033281771 scopus 로고    scopus 로고
    • How many more breast cancer predisposition genes are there?
    • D. F. Easton (1999). How many more breast cancer predisposition genes are there? Breast Cancer Res. 1:14-17.
    • (1999) Breast Cancer Res. , vol.1 , pp. 14-17
    • Easton, D.F.1
  • 118
    • 0034936364 scopus 로고    scopus 로고
    • Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study
    • A. C. Antoniou, P. D. Pharoah, G. McMullan, N. E. Day, B. A. Ponder, and D. Easton (2001). Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet. Epidemiol. 21:1-18.
    • (2001) Genet. Epidemiol. , vol.21 , pp. 1-18
    • Antoniou, A.C.1    Pharoah, P.D.2    McMullan, G.3    Day, N.E.4    Ponder, B.A.5    Easton, D.6
  • 122
    • 0031045260 scopus 로고    scopus 로고
    • Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: Linkage analysis in German breast cancer families
    • S. Seitz, K. Rohde, E. Bender, A. Nothnagel, K. Kolble, P. M. Schlag, and S. Scherneck (1997). Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: Linkage analysis in German breast cancer families. Oncogene 14:741-743.
    • (1997) Oncogene , vol.14 , pp. 741-743
    • Seitz, S.1    Rohde, K.2    Bender, E.3    Nothnagel, A.4    Kolble, K.5    Schlag, P.M.6    Scherneck, S.7
  • 126
    • 0037471838 scopus 로고    scopus 로고
    • Prediction of pathogenic mutations in patients with early-onset breast cancer by family history
    • F. Lalloo, J. Varley, D. Ellis, A. Moran, L. O'Dair, P. Pharoah, and D. G. Evans (2003). Prediction of pathogenic mutations in patients with early-onset breast cancer by family history. Lancet 361: 101-1102.
    • (2003) Lancet , vol.361 , pp. 1101-1102
    • Lalloo, F.1    Varley, J.2    Ellis, D.3    Moran, A.4    O'Dair, L.5    Pharoah, P.6    Evans, D.G.7
  • 128
    • 0034848175 scopus 로고    scopus 로고
    • Breast cancer, Cowden disease and PTEN-MATCHS syndrome
    • S. Ball, M. Arolker, and A. D. Purushotham (2001). Breast cancer, Cowden disease and PTEN-MATCHS syndrome. Eur. J. Surg. Oncol. 27:604-606.
    • (2001) Eur. J. Surg. Oncol. , vol.27 , pp. 604-606
    • Ball, S.1    Arolker, M.2    Purushotham, A.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.